Skip to content

Evaluation of the Clinical Value of Different Endoscopic Treatments for Small Rectal Neuroendocrine Tumors

Evaluation of the Clinical Value of Different Endoscopic Treatments for Small Rectal Neuroendocrine Tumors

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600118449
Enrollment
Unknown
Registered
2026-02-05
Start date
2026-02-09
Completion date
Unknown
Last updated
2026-02-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rectal neuroendocrine tumor

Interventions

Intervention Group 2:EMR-L Band ligation-assisted endoscopic mucosal resection
Control Group:ESD Endoscopic submucosal dissection
Intervention Group 1:CA-ESMR Titanium clip-assisted submucosal resection

Sponsors

Chengdu Second People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Age 18-80 years; 2. Diagnosed with rectal neuroendocrine tumor by endoscopy and endoscopic ultrasonography; 3. Tumor diameter <= 10 mm; 4. Tumor confined to the submucosa (T1 stage); 5. Voluntarily participate in the study and sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Tumor invades the muscular layer or has lymph node metastasis; 2. Severe cardiopulmonary disease or other major conditions that contraindicate endoscopic treatment; 3. Pregnant or lactating women; 4. Coagulation disorders or current use of anticoagulant medications.

Design outcomes

Primary

MeasureTime frame
R0 resection rate;

Secondary

MeasureTime frame
recurrence rate;Disease-free survival;safety;Complexity of equipment usage;operation time;surgical cost;

Countries

China

Contacts

Public ContactWu Wen

Chengdu Second People's Hospital

wenwu2@qq.com+86 189 8062 3591

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 15, 2026